Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Moodys
Deloitte
Daiichi Sankyo
Teva
McKesson
Chubb
Cantor Fitzgerald

Generated: January 21, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: Lek Pharm

« Back to Dashboard

Lek Pharm Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Lek Pharm acyclovir 074658 400MG TABLET;ORAL
Lek Pharm acyclovir 074658 800MG TABLET;ORAL
Lek Pharm acyclovir 074750 200MG CAPSULE;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Harvard Business School
Johnson and Johnson
Deloitte
Mallinckrodt
US Army
Accenture
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.